iManagement

Bee venom therapy (BVT)

Which statement most accurately describes the current state of scientific knowledge on apitherapy by injection of bee venom, often referred to as BVT (Bee Venom Therapy)?

  1. BVT has a robust and reproducible clinical efficacy, comparable to that of venom immunotherapy.
  2. BVT is a standardized immunotherapy based on validated and widely recognized clinical protocols.
  3. The literature suggests at best limited and heterogeneous clinical effects, with substantial risks of methodological bias.
  4. BVT is recommended as a therapeutic alternative for beekeepers who are allergic to bee venom.

Correct answer: 3.
The literature suggests at best limited and heterogeneous clinical effects, with substantial risks of methodological bias.

Why?

Apitherapy with bee venom, or BVT, must not be confused with venom immunotherapy, or VIT, which is used in allergology to prevent systemic reactions in allergic individuals. Studies on BVT are often few in number, small in size, heterogeneous in their protocols, and susceptible to selection, publication, or interpretation bias.

Some studies explore anti-inflammatory or analgesic effects of the venom, but this is not sufficient to demonstrate a robust, reproducible clinical efficacy applicable in routine practice. Moreover, the injection of venom can cause adverse reactions, including severe allergic reactions in susceptible individuals.

 

What you need to understand

VIT is a standardized medical treatment for hymenoptera venom allergy, carried out by specialists, with defined indications, doses, and monitoring. BVT, by contrast, falls rather within complementary or experimental practices, with variable therapeutic objectives and much more uncertain levels of evidence.

In a beekeeper who has had a generalized reaction after a sting, the question is therefore not whether to resort to BVT, but to request an allergological assessment. Individual risk cannot simply be inferred from the number of stings already received or from an apparent tolerance.

 

Key takeaways

BVT does not constitute a validated alternative to venom immunotherapy. It should not be presented as a safe or effective method for treating a bee venom allergy.

For beekeepers, the practical message is clear: in the event of a systemic reaction, malaise, breathing difficulty, generalized urticaria, or any doubt, a specialized medical evaluation is necessary.

 

Further reading

Back to overview